Therapy for Ocular Toxoplasmosis – The Future

Author： Garweg Justus G.   Stanford Miles R.  

Publisher： Informa Healthcare

ISSN： 0927-3948

Source： Ocular Immunology and Inflammation, Vol.21, Iss.4, 2013-08, pp. : 300-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy for Ocular Toxoplasmosis

By de-la-Torre Alejandra   Stanford Miles   Curi Andre   Jaffe Glenn J.   Gomez-Marin Jorge E.  

Ocular Immunology and Inflammation, Vol. 19, Iss. 5, 2011-10 ,pp. : 314-320

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology, Pathophysiology, and the Future of Ocular Toxoplasmosis

By Kijlstra Aize   Petersen Eskild  

Ocular Immunology and Inflammation, Vol. 22, Iss. 2, 2014-04 ,pp. : 138-147

Informa Healthcare

Access to resources Recommend Favorite

Trimethoprim/Sulfamethoxazole and Azithromycin Combination Therapy for Ocular Toxoplasmosis

By Yazici Alper   Ozdal Pınar Cakar   Taskintuna Ibrahim   Kavuncu Sevim   Koklu Gultekin  

Ocular Immunology and Inflammation, Vol. 17, Iss. 4, 2009-08 ,pp. : 289-291

Informa Healthcare

Access to resources Recommend Favorite

Clinical Manifestations of Ocular Toxoplasmosis

By Delair Emmanuelle   Latkany Paul   Noble A. Gwendolyn   Rabiah Peter   McLeod Rima   Bréézin Antoine  

Ocular Immunology and Inflammation, Vol. 19, Iss. 2, 2011-04 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology of Ocular Toxoplasmosis

By Petersen Eskild   Kijlstra Aize   Stanford Miles  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 68-75

Informa Healthcare

Access to resources Recommend Favorite